Drug companies fines £260 million for competition law breaches
LONDON, UK: Competition and Markets Authority (CMA) has imposed fines totalling over £260 million for competition law breaches in relation to the supply of hydrocortisone tablets. The fines are the result of a Competition and Markets Authority (CMA) investigation into…